Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-09

FDA Approved: REZENOPY — Supplemental Application (Scienture LLC)

View source ↗

Summary

FDA approved a supplemental application for REZENOPY (naloxone HCl) filed by Scienture LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REZENOPY (Naloxone HCl)

Snippet

SUPPL AP for REZENOPY (NALOXONE HCL)